Identification of TYK2 activators. Part 2: Optimization of terminal alkyne substituents to enhance activation potency
Hirokazu Matsumoto1, Tien-Cheng Wang1, Fumio Nakajima1
1Drug Discovery Unit, Carna Biosciences, Inc., Kobe 650-0047, Japan.
Abstract:
Tyrosine kinase 2 (TYK2) plays a key role in immune signaling, and its inhibition has been clinically validated for autoimmune diseases. Conversely, activation of TYK2 is expected to enhance antitumor immunity, representing a novel therapeutic strategy in cancer immunotherapy. In our previous study, we identified compound 2, an alkyne-containing derivative, as a novel TYK2 activator through a scaffold-repurposing design strategy based on a known TYK2 inhibitor that binds to the JH2 pseudokinase domain. Here, we expanded our SAR study to explore substituents at the terminal alkyne position based on JH2-domain docking study results. We found the phenylalkyne analog 6g was the most potent activator, with an EC50 of 0.21 μM and a maximal activation effect (Emax) of 7.8-fold.
Insights
Researchers identified a novel Tyrosine Kinase 2 (TYK2) activator, compound 6fg, for potential cancer immunotherapy. This phenylalkyne analog shows potent activation, offering a new strategy to boost antitumor immunity.
Area of Science:
- Biochemistry
- Immunology
- Medicinal Chemistry
Background:
- Tyrosine Kinase 2 (TYK2) is crucial in immune signaling.
- TYK2 inhibition treats autoimmune diseases.
- TYK2 activation may enhance antitumor immunity for cancer immunotherapy.
Purpose of the Study:
- To identify novel TYK2 activators for cancer immunotherapy.
- To expand structure-activity relationship (SAR) studies of previously identified TYK2 activators.
- To explore substituents at the terminal alkyne position of TYK2 activators.
Main Methods:
- Scaffold-repurposing design strategy based on a known TYK2 inhibitor.
- JH2 pseudokinase domain docking studies.
- Structure-activity relationship (SAR) exploration of alkyne-containing TYK2 activators.
Main Results:
- Compound 2, an alkyne-containing derivative, was identified as a novel TYK2 activator.
- Phenylalkyne analog 6fg emerged as the most potent activator.
- Compound 6fg demonstrated an EC50 of 0.21 μM and a 7.8-fold maximal activation effect (Emax).
Conclusions:
- The phenylalkyne analog 6fg is a highly potent TYK2 activator.
- This finding supports TYK2 activation as a promising strategy in cancer immunotherapy.
- Further development of TYK2 activators could lead to new cancer treatments.
More Related Videos
10:10Application of Elemental Lanthanides in the Selective C-F Activation of Trifluoromethylated Benzofulvenes Providing Access to Various Difluoroalkenes
Published on: July 28, 2018
10:17Efficient Construction of Drug-like Bispirocyclic Scaffolds Via Organocatalytic Cycloadditions of α-Imino γ-Lactones and Alkylidene Pyrazolones
Published on: February 7, 2019
Related Concept Videos
Preparation of Alkynes: Alkylation Reaction
Alkylation of terminal alkynes with primary alkyl halides in the presence of a strong base like sodium amide is one of the common methods for the synthesis of longer carbon-chain alkynes. For example, treatment of 1-propyne with sodium amide followed by reaction with ethyl bromide yields 2-pentyne.
Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence, side reactions...
Alkynes to Aldehydes and Ketones: Hydroboration-Oxidation
One of the convenient methods for the preparation of aldehydes and ketones is via hydration of alkynes. Hydroboration-oxidation of alkynes is an indirect hydration reaction in which an alkyne is treated with borane followed by oxidation with alkaline peroxide to form an enol that rapidly converts into an aldehyde or a ketone. Terminal alkynes form aldehydes, whereas internal alkynes give ketones as the final product.
Cycloaddition Reactions: MO Requirements for Thermal Activation
Reduction of Alkynes to cis-Alkenes: Catalytic Hydrogenation
Like alkenes, alkynes can be reduced to alkanes in the presence of transition metal catalysts such as Pt, Pd, or Ni. The reaction involves two sequential syn additions of hydrogen via a cis-alkene intermediate.
Preparation of Alkynes: Dehydrohalogenation
Alkynes can be prepared by dehydrohalogenation of vicinal or geminal dihalides in the presence of a strong base like sodium amide in liquid ammonia. The reaction proceeds with the loss of two equivalents of hydrogen halide (HX) via two successive E2 elimination reactions.
